Details for New Drug Application (NDA): 217243
✉ Email this page to a colleague
The generic ingredient in PIPERACILLIN AND TAZOBACTAM is piperacillin sodium; tazobactam sodium. There are sixteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.
Summary for 217243
Tradename: | PIPERACILLIN AND TAZOBACTAM |
Applicant: | Shandong |
Ingredient: | piperacillin sodium; tazobactam sodium |
Patents: | 0 |
Pharmacology for NDA: 217243
Mechanism of Action | beta Lactamase Inhibitors |
Suppliers and Packaging for NDA: 217243
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 217243 | ANDA | Shandong Anxin Pharmaceutical Co., Ltd. | 35369-0504 | 35369-0504-1 | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (35369-0504-1) / 180 mL in 1 VIAL, PHARMACY BULK PACKAGE |
PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 217243 | ANDA | Apotex Corp. | 60505-6262 | 60505-6262-0 | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (60505-6262-0) / 180 mL in 1 VIAL, PHARMACY BULK PACKAGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | ||||
Approval Date: | Apr 14, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription